Browsing Tag
HT-001
2 posts
Hoth Therapeutics (NASDAQ: HOTH) stakes claim on emerging oncodermatology space with dual patent filings for HT-001
Hoth Therapeutics files dual patents for HT-001 in oncology dermatology. Find out what this means for its IP strategy and cancer care positioning.
Hoth Therapeutics advances HT-001 as promising therapy for EGFR inhibitor-related skin toxicities
Hoth Therapeutics, Inc. has announced positive findings for HT-001 treatment, positioning it as a potential breakthrough therapy for…